{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:56:45Z","timestamp":1793642205171,"version":"4.5.1"},"reference-count":233,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T00:00:00Z","timestamp":1681689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.pharmthera.2023.108412","type":"journal-article","created":{"date-parts":[[2023,4,8]],"date-time":"2023-04-08T10:48:20Z","timestamp":1680950900000},"page":"108412","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Is fat the future for saving sight? Bioactive lipids and their impact on glaucoma"],"prefix":"10.1016","volume":"245","author":[{"given":"Miriam","family":"Kolko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaynab Ahmad","family":"Mouhammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Cvenkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2023.108412_bb0005","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/ceo.14035","article-title":"The genetics of glaucoma: Disease associations, personalised risk assessment and therapeutic opportunities-A review","volume":"50","author":"Aboobakar","year":"2022","journal-title":"Clinical & Experimental Ophthalmology"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0010","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.exer.2009.07.008","article-title":"Red blood cell plasmalogens and docosahexaenoic acid are independently reduced in primary open-angle glaucoma","volume":"89","author":"Acar","year":"2009","journal-title":"Experimental Eye Research"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0015","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.exer.2008.01.013","article-title":"Extracellular matrix in the trabecular meshwork","volume":"86","author":"Acott","year":"2008","journal-title":"Experimental Eye Research"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100897","article-title":"Normal and glaucomatous outflow regulation","volume":"82","author":"Acott","year":"2021","journal-title":"Progress in Retinal and Eye Research"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0025","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.jnutbio.2009.12.004","article-title":"Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids","volume":"21","author":"Adkins","year":"2010","journal-title":"The Journal of Nutritional Biochemistry"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/nu12103158","article-title":"Natural products: Evidence for neuroprotection to be exploited in glaucoma","volume":"12","author":"Adornetto","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0035","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1136\/bjophthalmol-2012-302597","article-title":"In vivo confocal microscopy of meibomian glands in glaucoma","volume":"97","author":"Agnifili","year":"2013","journal-title":"The British Journal of Ophthalmology"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0040","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/jb\/mvu077","article-title":"Lysophosphatidic acid as a lipid mediator with multiple biological actions","volume":"157","author":"Aikawa","year":"2015","journal-title":"Journal of Biochemistry"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0045","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/imm.12233","article-title":"Inflammation in neurodegenerative diseases\u2014an update","volume":"142","author":"Amor","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0050","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.neuroscience.2022.11.001","article-title":"Resolvins lipid mediators: Potential therapeutic targets in Alzheimer and parkinson disease","volume":"507","author":"Anand","year":"2022","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0055","article-title":"Targeted lipidomic analysis of aqueous humor reveals signaling lipid-mediated pathways in primary open-angle glaucoma","volume":"10","author":"Azbukina","year":"2021","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0060","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ajo.2007.09.001","article-title":"Prostaglandins increase trabecular meshwork outflow facility in cultured human anterior segments","volume":"145","author":"Bahler","year":"2008","journal-title":"American Journal of Ophthalmology"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2021.146078","article-title":"Circulating fatty acids and risk of primary open-angle glaucoma: A mendelian randomization study","volume":"811","author":"Bao","year":"2022","journal-title":"Gene"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100916","article-title":"Inflammation in Glaucoma: From the back to the front of the eye, and beyond","volume":"83","author":"Baudouin","year":"2021","journal-title":"Progress in Retinal and Eye Research"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0075","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ophtha.2007.01.036","article-title":"The ocular surface of glaucoma patients treated over the long term expresses inflammatory markers related to both T-helper 1 and T-helper 2 pathways","volume":"115","author":"Baudouin","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0080","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s12017-020-08630-2","article-title":"Lysophosphatidic acid signalling in nervous system development and function","volume":"23","author":"Birgbauer","year":"2021","journal-title":"Neuromolecular Medicine"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0085","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1023\/A:1006279606494","article-title":"Circulating platelet aggregates in glaucoma","volume":"22","author":"Bojic","year":"1998","journal-title":"International Ophthalmology"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0090","doi-asserted-by":"crossref","first-page":"9364091","DOI":"10.1155\/2016\/9364091","article-title":"The endocannabinoid system as a therapeutic target in glaucoma","volume":"2016","author":"Cairns","year":"2016","journal-title":"Neural Plasticity"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0095","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s11745-003-1068-y","article-title":"N-3 polyunsaturated fatty acids and inflammation: From molecular biology to the clinic","volume":"38","author":"Calder","year":"2003","journal-title":"Lipids"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0100","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1016\/j.ophtha.2004.06.028","article-title":"Detection of the free acid of bimatoprost in aqueous humor samples from human eyes treated with bimatoprost before cataract surgery","volume":"111","author":"Camras","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0105","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bjo.2006.110155","article-title":"Levels of bimatoprost acid in the aqueous humour after bimatoprost treatment of patients with cataract","volume":"91","author":"Cantor","year":"2007","journal-title":"The British Journal of Ophthalmology"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0110","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1600-0420.1998.tb00880.x","article-title":"Fatty acid use in glaucomatous optic neuropathy treatment","author":"Cellini","year":"1998","journal-title":"Acta Ophthalmologica Scandinavica. Supplement"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0115","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1167\/iovs.18-25802","article-title":"Optic nerve lipidomics reveal impaired glucosylsphingosine lipids pathway in glaucoma","volume":"60","author":"Chauhan","year":"2019","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0120","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12886-021-01910-w","article-title":"Plasma fatty acids and primary open-angle glaucoma in the elderly: The Montrachet population-based study","volume":"21","author":"Chemaly","year":"2021","journal-title":"BMC Ophthalmology"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0125","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.bbrc.2005.03.095","article-title":"Finding of endocannabinoids in human eye tissues: Implications for glaucoma","volume":"330","author":"Chen","year":"2005","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0130","article-title":"Vitamin B3 provides neuroprotection via antioxidative stress in a rat model of anterior ischemic optic neuropathy","volume":"11","author":"Chen","year":"2022","journal-title":"Antioxidants (Basel, Switzerland)"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0135","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1001\/archopht.121.1.87","article-title":"Effect of WIN 55212-2, a cannabinoid receptor agonist, on aqueous humor dynamics in monkeys","volume":"121","author":"Chien","year":"2003","journal-title":"Archives of Ophthalmology"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0140","first-page":"23","article-title":"Lipidomics of bioactive lipids in Alzheimer\u2019s and Parkinson\u2019s diseases: Where are we?","author":"Chiurchi\u00f9","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0145","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/j.ophtha.2004.02.006","article-title":"Mechanism of ocular hypotensive action of bimatoprost (Lumigan) in patients with ocular hypertension or glaucoma","volume":"111","author":"Christiansen","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0150","first-page":"1117","article-title":"Regulation of connective tissue growth factor expression in the aqueous humor outflow pathway","volume":"12","author":"Chudgar","year":"2006","journal-title":"Molecular Vision"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0155","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.exer.2008.10.004","article-title":"The role of steroids in outflow resistance","volume":"88","author":"Clark","year":"2009","journal-title":"Experimental Eye Research"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0160","doi-asserted-by":"crossref","first-page":"6511","DOI":"10.1167\/iovs.11-7909","article-title":"Mapping the differential distribution of glycosaminoglycans in the adult human retina, choroid, and sclera","volume":"52","author":"Clark","year":"2011","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0165","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0014-4835(84)90139-8","article-title":"Intraocular pressure, ocular toxicity and neurotoxicity after administration of delta 9-tetrahydrocannabinol or cannabichromene","volume":"38","author":"Colasanti","year":"1984","journal-title":"Experimental Eye Research"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0170","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","article-title":"TFOS DEWS II definition and classification report","volume":"15","author":"Craig","year":"2017","journal-title":"The Ocular Surface"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0175","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/IJG.0000000000000316","article-title":"Vitamin A palmitate and carbomer gel protects the conjunctiva of patients with long-term prostaglandin analogs application","volume":"25","author":"Cui","year":"2016","journal-title":"Journal of Glaucoma"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0180","doi-asserted-by":"crossref","first-page":"6138132","DOI":"10.1155\/2020\/6138132","article-title":"Current medical therapy and future trends in the management of glaucoma treatment","volume":"2020","author":"Cvenkel","year":"2020","journal-title":"Journal of Ophthalmology"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0185","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1038\/s41467-019-09654-4","article-title":"Ceramides bind VDAC2 to trigger mitochondrial apoptosis","volume":"10","author":"Dadsena","year":"2019","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0190","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/978-1-4615-0717-8_103","article-title":"Role of immunity and inflammation in corneal and ocular surface disease associated with dry eye","volume":"506","author":"Dana","year":"2002","journal-title":"Advances in Experimental Medicine and Biology"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0195","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1001\/jamaophthalmol.2021.4576","article-title":"Nicotinamide and pyruvate for neuroenhancement in open-angle glaucoma: A phase 2 randomized clinical trial","volume":"140","author":"De Moraes","year":"2022","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0200","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1167\/iovs.61.8.40","article-title":"The effect of dietary vitamin K1 supplementation on trabecular meshwork and retina in a chronic ocular hypertensive rat model","volume":"61","author":"Deng","year":"2020","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0205","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3109\/13816810.2016.1164193","article-title":"Prostaglandins in the eye: Function, expression, and roles in glaucoma","volume":"38","author":"Doucette","year":"2017","journal-title":"Ophthalmic Genetics"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0210","first-page":"CD011016","article-title":"Omega-3 and omega-6 polyunsaturated fatty acids for dry eye disease","volume":"12","author":"Downie","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0215","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.1111\/jcmm.14975","article-title":"Endogenous ocular lipids as potential modulators of intraocular pressure","volume":"24","author":"Edwards","year":"2020","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0220","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.890021","article-title":"Molecular mechanisms underlying the therapeutic role of vitamin E in age-related macular degeneration","volume":"16","author":"Edwards","year":"2022","journal-title":"Frontiers in Neuroscience"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0225","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/bph.14507","article-title":"Bioactive lipids and pathological retinal angiogenesis","volume":"176","author":"Elmasry","year":"2019","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0230","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.plefa.2017.01.004","article-title":"Identification and profiling of specialized pro-resolving mediators in human tears by lipid mediator metabolomics","volume":"117","author":"English","year":"2017","journal-title":"Prostaglandins, Leukotrienes, and Essential Fatty Acids"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0235","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.ophtha.2012.09.005","article-title":"An evidence-based review of prognostic factors for glaucomatous visual field progression","volume":"120","author":"Ernest","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2022.109250","article-title":"Sphingomyelinases in retinas and optic nerve heads: Effects of ocular hypertension and ischemia","volume":"224","author":"Fan","year":"2022","journal-title":"Experimental Eye Research"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0245","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2174\/1871529X14666140505125300","article-title":"Glucagon-like peptide-1 as a key regulator of lipid and lipoprotein metabolism in fasting and postprandial states","volume":"14","author":"Farr","year":"2014","journal-title":"Cardiovascular & Hematological Disorders Drug Targets"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0250","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jtos.2022.07.007","article-title":"Topical glaucoma medications - Clinical implications for the ocular surface","volume":"26","author":"Fineide","year":"2022","journal-title":"The Ocular Surface"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0255","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s13167-017-0090-x","article-title":"The discovery of the Flammer syndrome: A historical and personal perspective","volume":"8","author":"Flammer","year":"2017","journal-title":"The EPMA Journal"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0260","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1750-1326-4-47","article-title":"Does neuroinflammation fan the flame in neurodegenerative diseases?","volume":"4","author":"Frank-Cannon","year":"2009","journal-title":"Molecular Neurodegeneration"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0265","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/02713683.2020.1815791","article-title":"RhoA activation decreases phagocytosis of trabecular meshwork cells","volume":"46","author":"Fujimoto","year":"2021","journal-title":"Current Eye Research"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0270","first-page":"711","article-title":"Patients undergoing long-term treatment with antihypertensive eye drops responded positively with respect to their ocular surface disorder to oral supplementation with antioxidants and essential fatty acids","volume":"8","author":"Galbis-Estrada","year":"2013","journal-title":"Clinical Interventions in Aging"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0275","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jtos.2021.11.011","article-title":"Meibum sphingolipid composition is altered in individuals with meibomian gland dysfunction-a side by side comparison of Meibum and Tear Sphingolipids","volume":"23","author":"Galor","year":"2022","journal-title":"The Ocular Surface"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0280","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.624983","article-title":"Glial cells in glaucoma: Friends, foes, and potential therapeutic targets","volume":"12","author":"Garc\u00eda-Berm\u00fadez","year":"2021","journal-title":"Frontiers in Neurology"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0285","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1001\/archopht.120.6.714","article-title":"The Ocular Hypertension Treatment Study: Baseline factors that predict the onset of primary open-angle glaucoma","volume":"120","author":"Gordon","year":"2002","journal-title":"Archives of Ophthalmology"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0290","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1523\/JNEUROSCI.10-07-02190.1990","article-title":"Docosahexaenoic acid utilization during rod photoreceptor cell renewal","volume":"10","author":"Gordon","year":"1990","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0295","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0014-4835(78)90092-1","article-title":"A comparison of topical cannabinoids on intraocular pressure","volume":"27","author":"Green","year":"1978","journal-title":"Experimental Eye Research"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0300","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s40263-014-0144-8","article-title":"Neuroprotective properties of citicoline: Facts, doubts and unresolved issues","volume":"28","author":"Grieb","year":"2014","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0305","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23073969","article-title":"Emerging role of phospholipids and lysophospholipids for improving brain docosahexaenoic acid as potential preventive and therapeutic strategies for neurological diseases","volume":"23","author":"Hachem","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0310","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jfo.2021.10.010","article-title":"Vitamin intake and glaucoma risk: A systematic review and meta-analysis","volume":"45","author":"Han","year":"2022","journal-title":"Journal Fran\u00e7ais d\u2019Ophtalmologie"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0315","doi-asserted-by":"crossref","first-page":"89","DOI":"10.7812\/TPP\/21.204","article-title":"B vitamins: Functions and uses in medicine","volume":"26","author":"Hanna","year":"2022","journal-title":"The Permanente Journal"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0320","article-title":"Suppression of oxidative stress as potential therapeutic approach for normal tension glaucoma","volume":"9","author":"Harada","year":"2020","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0325","doi-asserted-by":"crossref","first-page":"11469","DOI":"10.1074\/jbc.M111.256073","article-title":"Essential role of ELOVL4 protein in very long chain fatty acid synthesis and retinal function","volume":"287","author":"Harkewicz","year":"2012","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0330","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.pharmthera.2004.06.003","article-title":"Pharmacology and signaling of prostaglandin receptors: Multiple roles in inflammation and immune modulation","volume":"103","author":"Hata","year":"2004","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0335","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1001\/jama.1971.03190100074024","article-title":"Marihuana smoking and intraocular pressure","volume":"217","author":"Hepler","year":"1971","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0340","doi-asserted-by":"crossref","first-page":"165560","DOI":"10.1016\/j.bbadis.2019.165560","article-title":"Role of the autotaxin-lysophosphatidic acid axis in glaucoma, aqueous humor drainage and fibrogenic activity","volume":"1866","author":"Ho","year":"2020","journal-title":"Biochimica et Biophysica Acta, Molecular Basis of Disease"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0345","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1167\/iovs.17-23702","article-title":"Lysophosphatidic acid induces ecm production via activation of the mechanosensitive YAP\/TAZ transcriptional pathway in trabecular meshwork cells","volume":"59","author":"Ho","year":"2018","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0350","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1167\/iovs.17-23218","article-title":"Autotaxin-lysophosphatidic acid pathway in intraocular pressure regulation and glaucoma subtypes","volume":"59","author":"Honjo","year":"2018","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0355","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1167\/iovs.17-22807","article-title":"Role of the Autotaxin-LPA pathway in dexamethasone-induced fibrotic responses and extracellular matrix production in human trabecular meshwork cells","volume":"59","author":"Honjo","year":"2018","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0360","doi-asserted-by":"crossref","first-page":"5549","DOI":"10.1167\/iovs.07-0878","article-title":"Potential role of Rho-associated protein kinase inhibitor Y-27632 in glaucoma filtration surgery","volume":"48","author":"Honjo","year":"2007","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0365","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1161\/HYPERTENSIONAHA.116.08068","article-title":"Antihypertensive medication postpones the onset of glaucoma: Evidence from a nationwide study","volume":"69","author":"Horwitz","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0370","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF00918934","article-title":"Platelet aggregation, disc haemorrhage and progressive loss of visual fields in glaucoma. A seven year follow-up study on glaucoma","volume":"16","author":"Hoyng","year":"1992","journal-title":"International Ophthalmology"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0375","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ejpb.2015.06.001","article-title":"Dual drug delivery from vitamin E loaded contact lenses for glaucoma therapy","volume":"94","author":"Hsu","year":"2015","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0380","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1124\/jpet.111.185769","article-title":"Indirect sympatholytic actions at beta-adrenoceptors account for the ocular hypotensive actions of cannabinoid receptor agonists","volume":"339","author":"Hudson","year":"2011","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0385","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/ceo.13818","article-title":"Improvement in inner retinal function in glaucoma with nicotinamide (vitamin B3) supplementation: A crossover randomized clinical trial","volume":"48","author":"Hui","year":"2020","journal-title":"Clinical & Experimental Ophthalmology"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0390","article-title":"Synthesis, characterization, and in vivo evaluation of a novel potent autotaxin-inhibitor","volume":"12","author":"Hunziker","year":"2021","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0395","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1136\/bjophthalmol-2020-316331","article-title":"Low systemic vitamin D as a potential risk factor in primary open-angle glaucoma: A review of current evidence","volume":"105","author":"Huynh","year":"2021","journal-title":"The British Journal of Ophthalmology"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0400","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40942-022-00392-2","article-title":"Effect of retinol and \u03b1-tocopherol supplementation on photoreceptor and retinal ganglion cell apoptosis in diabetic rats model","volume":"8","author":"Ichsan","year":"2022","journal-title":"Int J Retina Vitreous"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0405","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1038\/s41598-021-81048-3","article-title":"Aqueous autotaxin and TGF-betas are promising diagnostic biomarkers for distinguishing open-angle glaucoma subtypes","volume":"11","author":"Igarashi","year":"2021","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0410","doi-asserted-by":"crossref","first-page":"11304","DOI":"10.1038\/s41598-018-29649-3","article-title":"Increased aqueous autotaxin and lysophosphatidic acid levels are potential prognostic factors after trabeculectomy in different types of glaucoma","volume":"8","author":"Igarashi","year":"2018","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0415","doi-asserted-by":"crossref","first-page":"6265","DOI":"10.1038\/s41598-020-63284-1","article-title":"Involvement of autotaxin in the pathophysiology of elevated intraocular pressure in Posner-Schlossman syndrome","volume":"10","author":"Igarashi","year":"2020","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0420","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042627","article-title":"Autotaxin-lysophosphatidic acid axis is a novel molecular target for lowering intraocular pressure","volume":"7","author":"Iyer","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0425","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(95)91148-0","article-title":"Fat-soluble vitamins","volume":"345","author":"James","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0430","article-title":"Autotaxin protects retinal ganglion cells in an autoimmune glaucoma model","volume":"59","author":"Joachim","year":"2018","journal-title":"Investigative Ophthalmology and Visual Science"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0435","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1021\/jm301485d","article-title":"Structure-activity relationship study of vitamin k derivatives yields highly potent neuroprotective agents","volume":"56","author":"Josey","year":"2013","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0440","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1002\/1878-0261.13209","article-title":"Nicotinamide (niacin) supplement increases lipid metabolism and ROS-induced energy disruption in triple-negative breast cancer: Potential for drug repositioning as an anti-tumor agent","volume":"16","author":"Jung","year":"2022","journal-title":"Molecular Oncology"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0445","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10123126","article-title":"Lysophospholipids: A potential drug candidates for neurodegenerative disorders","volume":"10","author":"Karaki","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0450","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.metabol.2015.04.005","article-title":"Low blood and vitreal BDNF, LXA4 and altered Th1\/Th2 cytokine balance are potential risk factors for diabetic retinopathy","volume":"64","author":"Kaviarasan","year":"2015","journal-title":"Metabolism"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0455","doi-asserted-by":"crossref","first-page":"7528","DOI":"10.1167\/iovs.12-10797","article-title":"Mapping the differential distribution of proteoglycan core proteins in the adult human retina, choroid, and sclera","volume":"53","author":"Keenan","year":"2012","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0460","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201801076","article-title":"Fair-weather friends: Evidence of lipoxin dysregulation in neurodegeneration","volume":"64","author":"Kim","year":"2020","journal-title":"Molecular Nutrition & Food Research"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0465","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1159\/000310829","article-title":"Effect of retinol palmitate as a treatment for dry eye: A cytological evaluation","volume":"211","author":"Kobayashi","year":"1997","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0470","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/IIO.0000000000000231","article-title":"Trabeculectomy: A brief history and review of current trends","volume":"58","author":"Koike","year":"2018","journal-title":"International Ophthalmology Clinics"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0475","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132048","article-title":"The prevalence and incidence of glaucoma in denmark in a fifteen year period: A nationwide study","volume":"10","author":"Kolko","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0480","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.3324\/haematol.2019.219519","article-title":"Specialized pro-resolving lipid mediators are differentially altered in peripheral blood of patients with multiple sclerosis and attenuate monocyte and blood-brain barrier dysfunction","volume":"105","author":"Kooij","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0485","doi-asserted-by":"crossref","first-page":"639","DOI":"10.18388\/abp.2014_1825","article-title":"Cyclooxygenase pathways","volume":"61","author":"Korbecki","year":"2014","journal-title":"Acta Biochimica Polonica"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0490","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1167\/iovs.19-27099","article-title":"Nicotinamide deficiency in primary open-angle glaucoma","volume":"60","author":"Kouassi Nzoughet","year":"2019","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0495","first-page":"1178","article-title":"Prostaglandins E3 and D3 lower intraocular pressure","volume":"26","author":"Kulkarni","year":"1985","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0500","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.1167\/iovs.11-9294","article-title":"Effects of palmitoylethanolamide on aqueous humor outflow","volume":"53","author":"Kumar","year":"2012","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0505","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/jcb.22950","article-title":"Rho GTPase-mediated cytoskeletal organization in Schlemm\u2019s canal cells play a critical role in the regulation of aqueous humor outflow facility","volume":"112","author":"Kumar","year":"2011","journal-title":"Journal of Cellular Biochemistry"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0510","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9092979","article-title":"Increased antioxidant capacity and pro-homeostatic lipid mediators in ocular hypertension-a human experimental model","volume":"9","author":"Langbol","year":"2020","journal-title":"Journal of Clinical Medicine"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0515","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9092979","article-title":"Increased antioxidant capacity and pro-homeostatic lipid mediators in ocular hypertension-A human experimental model","volume":"9","author":"Langb\u00f8l","year":"2020","journal-title":"Journal of Clinical Medicine"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0520","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.mito.2017.05.003","article-title":"Systemic PTEN-Akt1-mTOR pathway activity in patients with normal tension glaucoma and ocular hypertension: A case series","volume":"36","author":"Lascaratos","year":"2017","journal-title":"Mitochondrion"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0525","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.nbd.2015.05.012","article-title":"Resistance to the most common optic neuropathy is associated with systemic mitochondrial efficiency","volume":"82","author":"Lascaratos","year":"2015","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0530","article-title":"Meibomian gland dropout rate as a method to assess meibomian gland morphologic changes during use of preservative-containing or preservative-free topical prostaglandin analogues","volume":"14","author":"Lee","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0535","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/IJG.0b013e31815c5f4f","article-title":"Prevalence of ocular surface disease in glaucoma patients","volume":"17","author":"Leung","year":"2008","journal-title":"Journal of Glaucoma"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0540","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.addr.2020.06.028","article-title":"Bioactive lipids, inflammation and chronic diseases","volume":"159","author":"Leuti","year":"2020","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0545","doi-asserted-by":"crossref","first-page":"5816","DOI":"10.1523\/JNEUROSCI.23-13-05816.2003","article-title":"Novel role of vitamin k in preventing oxidative injury to developing oligodendrocytes and neurons","volume":"23","author":"Li","year":"2003","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0550","doi-asserted-by":"crossref","DOI":"10.3390\/nu9060636","article-title":"Lack of association between serum vitamin B\u2086, Vitamin B(12), and Vitamin D levels with different types of glaucoma: A systematic review and meta-analysis","volume":"9","author":"Li","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0555","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/946813","article-title":"Role of prostaglandins in neuroinflammatory and neurodegenerative diseases","volume":"2012","author":"Lima","year":"2012","journal-title":"Mediators of Inflammation"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0560","first-page":"2214","article-title":"Prostaglandins alter extracellular matrix adjacent to human ciliary muscle cells in vitro","volume":"38","author":"Lindsey","year":"1997","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0565","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.1172\/JCI77398","article-title":"Astrocyte-derived lipoxins A4 and B4 promote neuroprotection from acute and chronic injury","volume":"127","author":"Livne-Bar","year":"2017","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0570","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.bbrc.2019.06.137","article-title":"Lipoxin A4 delays the progression of retinal degeneration via the inhibition of microglial overactivation","volume":"516","author":"Lu","year":"2019","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0575","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00417-014-2853-6","article-title":"Evaluation of oxidative stress levels in the conjunctival epithelium of patients with or without dry eye, and dry eye patients treated with preservative-free hyaluronic acid 0.15 % and vitamin B12 eye drops","volume":"253","author":"Macri","year":"2015","journal-title":"Graefe\u2019s Archive for Clinical and Experimental Ophthalmology"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0580","first-page":"Ns20210038","article-title":"Neuroprotection of retinal ganglion cells in vivo using the activation of the endogenous cannabinoid signaling system in mammalian eyes. Neuronal","volume":"6","author":"Maguire","year":"2022","journal-title":"Signal"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0585","first-page":"2616","article-title":"Expression of cyclooxygenase-1 and -2 in normal and glaucomatous human eyes","volume":"42","author":"Maihofner","year":"2001","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0590","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0952-3278(92)90120-8","article-title":"A comparative study between cod liver oil and liquid lard intake on intraocular pressure on rabbits","volume":"45","author":"Mancino","year":"1992","journal-title":"Prostaglandins, Leukotrienes, and Essential Fatty Acids"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0595","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.2147\/OPTH.S340386","article-title":"Efficacy and patient tolerability of omidenepag isopropyl in the treatment of glaucoma and ocular hypertension","volume":"16","author":"Matsuo","year":"2022","journal-title":"Clinical Ophthalmology"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0600","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.plipres.2007.02.001","article-title":"Regulation and biological activities of the autotaxin-LPA axis","volume":"46","author":"van Meeteren","year":"2007","journal-title":"Progress in Lipid Research"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0605","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0161-6420(80)35258-5","article-title":"Effect of marihuana on intraocular and blood pressure in glaucoma","volume":"87","author":"Merritt","year":"1980","journal-title":"Ophthalmology"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0610","doi-asserted-by":"crossref","first-page":"467S","DOI":"10.1002\/j.1552-4604.1981.tb02626.x","article-title":"Topical delta 9-tetrahydrocannabinol and aqueous dynamics in glaucoma","volume":"21","author":"Merritt","year":"1981","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0615","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1167\/iovs.03-0960","article-title":"Role of lysophospholipid growth factors in the modulation of aqueous humor outflow facility","volume":"45","author":"Mettu","year":"2004","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0620","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1167\/iovs.61.6.60","article-title":"Alteration in lysophospholipids and converting enzymes in glaucomatous optic nerves","volume":"61","author":"Milbeck","year":"2020","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0625","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.1167\/iovs.10-6510","article-title":"The role of the prostaglandin EP4 receptor in the regulation of human outflow facility","volume":"52","author":"Millard","year":"2011","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0630","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.108266","article-title":"Endocannabinoid metabolism and transport as targets to regulate intraocular pressure","volume":"201","author":"Miller","year":"2020","journal-title":"Experimental Eye Research"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0635","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.1167\/iovs.18-24838","article-title":"Delta9-Tetrahydrocannabinol and Cannabidiol Differentially Regulate Intraocular Pressure","volume":"59","author":"Miller","year":"2018","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0640","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/S0161-6420(96)30449-1","article-title":"Prevalence of open-angle glaucoma in Australia. The blue mountains eye study","volume":"103","author":"Mitchell","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0645","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1097\/IJG.0000000000000495","article-title":"The association of chronic topical prostaglandin analog use with meibomian gland dysfunction","volume":"25","author":"Mocan","year":"2016","journal-title":"Journal of Glaucoma"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0650","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/978-3-030-21735-8_14","article-title":"Role of Bioactive Sphingolipids in Inflammation and Eye Diseases","volume":"1161","author":"Mondal","year":"2019","journal-title":"Advances in Experimental Medicine and Biology"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0655","doi-asserted-by":"crossref","DOI":"10.3390\/nu14235129","article-title":"ACE-vitamin index and risk of glaucoma: The SUN project","volume":"14","author":"Moreno-Monta\u00f1\u00e9s","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0660","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.824054","article-title":"Glucagon-like peptide 1 receptor agonists - potential game changers in the treatment of glaucoma?","volume":"16","author":"Mouhammad","year":"2022","journal-title":"Frontiers in Neuroscience"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0665","doi-asserted-by":"crossref","first-page":"6482","DOI":"10.1167\/iovs.16-20671","article-title":"Growth differentiation factor-15-induced contractile activity and extracellular matrix production in human trabecular meshwork cells","volume":"57","author":"Muralidharan","year":"2016","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0670","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2021.108623","article-title":"Neuroprotective role of sphingolipid rheostat in excitotoxic retinal ganglion cell death","volume":"208","author":"Nakamura","year":"2021","journal-title":"Experimental Eye Research"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0675","first-page":"61","article-title":"Effects of topical TGF-\u03b21, TGF-\u03b22, ATX, and LPA on IOP elevation and regulation of the conventional aqueous humor outflow pathway","volume":"27","author":"Nakamura","year":"2021","journal-title":"Molecular Vision"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0680","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1167\/iovs.06-1355","article-title":"Involvement of the endocannabinoid system in retinal damage after high intraocular pressure-induced ischemia in rats","volume":"48","author":"Nucci","year":"2007","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0685","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.2147\/CIA.S48955","article-title":"A randomized, double-masked study to evaluate the effect of omega-3 fatty acids supplementation in meibomian gland dysfunction","volume":"8","author":"Ole\u00f1ik","year":"2013","journal-title":"Clinical Interventions in Aging"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0690","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/wrr.12929","article-title":"The lysophosphatidic acid axis in fibrosis: Implications for glaucoma","volume":"29","author":"O\u2019Regan","year":"2021","journal-title":"Wound Repair and Regeneration"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0695","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1111\/bph.13497","article-title":"An update on PPAR activation by cannabinoids","volume":"173","author":"O\u2019Sullivan","year":"2016","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0700","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232113156","article-title":"Topical Omega-3 fatty acids eyedrops in the treatment of dry eye and ocular surface disease: A systematic review","volume":"23","author":"Paik","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0705","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41398-022-02208-1","article-title":"Age-linked suppression of lipoxin A4 associates with cognitive deficits in mice and humans","volume":"12","author":"Pamplona","year":"2022","journal-title":"Translational Psychiatry"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0710","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1038\/s41433-021-01740-6","article-title":"Association of serum retinol concentration with normal-tension glaucoma","volume":"36","author":"Pang","year":"2022","journal-title":"Eye (London, England)"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0715","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1002\/jnr.24273","article-title":"Changes in ganglioside GM1 expression in glaucomic retina","volume":"96","author":"Pappenhagen","year":"2018","journal-title":"Journal of Neuroscience Research"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0720","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10633-005-7348-7","article-title":"Electrophysiological assessment of glaucomatous visual dysfunction during treatment with cytidine-5'-diphosphocholine (citicoline): A study of 8 years of follow-up","volume":"110","author":"Parisi","year":"2005","journal-title":"Documenta Ophthalmologica"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0725","doi-asserted-by":"crossref","first-page":"919","DOI":"10.2174\/1570159X15666170703111729","article-title":"Citicoline and retinal ganglion cells: Effects on morphology and function","volume":"16","author":"Parisi","year":"2018","journal-title":"Current Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0730","doi-asserted-by":"crossref","first-page":"791","DOI":"10.3109\/02713689508995801","article-title":"Ophthalmic arachidonylethanolamide decreases intraocular pressure in normotensive rabbits","volume":"14","author":"Pate","year":"1995","journal-title":"Current Eye Research"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0735","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0024-3205(98)00499-8","article-title":"Effect of the CB1 receptor antagonist, SR141716A, on cannabinoid-induced ocular hypotension in normotensive rabbits","volume":"63","author":"Pate","year":"1998","journal-title":"Life Sciences"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0740","doi-asserted-by":"crossref","first-page":"C749","DOI":"10.1152\/ajpcell.00317.2009","article-title":"Mechanistic basis of Rho GTPase-induced extracellular matrix synthesis in trabecular meshwork cells","volume":"298","author":"Pattabiraman","year":"2010","journal-title":"American Journal of Physiology. Cell Physiology"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0745","doi-asserted-by":"crossref","first-page":"20053","DOI":"10.1038\/s41598-020-77087-x","article-title":"Comparative lipidomic analysis of mammalian retinal ganglion cells and M\u00fcller glia in situ and in vitro using High-Resolution Imaging Mass Spectrometry","volume":"10","author":"Pereiro","year":"2020","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0750","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.ajo.2013.05.027","article-title":"Lifetime risk of blindness in open-angle glaucoma","volume":"156","author":"Peters","year":"2013","journal-title":"American Journal of Ophthalmology"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0755","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.ophtha.2014.12.004","article-title":"Threat to fixation at diagnosis and lifetime risk of visual impairment in open-angle glaucoma","volume":"122","author":"Peters","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0760","doi-asserted-by":"crossref","DOI":"10.3390\/cells10061402","article-title":"Neuroprotection in glaucoma: NAD(+)\/NADH redox state as a potential biomarker and therapeutic target","volume":"10","author":"Petriti","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0765","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2147\/CIA.S40640","article-title":"Effects of a nutraceutical formulation based on the combination of antioxidants and omega-3 essential fatty acids in the expression of inflammation and immune response mediators in tears from patients with dry eye disorders","volume":"8","author":"Pinazo-Duran","year":"2013","journal-title":"Clinical Interventions in Aging"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0770","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.780811","article-title":"Role of specialized pro-resolving mediators in reducing neuroinflammation in neurodegenerative disorders","volume":"14","author":"Ponce","year":"2022","journal-title":"Frontiers in Aging Neuroscience"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0775","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1046\/j.0953-816X.2000.01401.x","article-title":"The synthetic cannabinoid WIN55212-2 decreases the intraocular pressure in human glaucoma resistant to conventional therapies","volume":"13","author":"Porcella","year":"2001","journal-title":"The European Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0780","first-page":"921","article-title":"Delta(9)-tetrahydrocannabinol,, euphoria and intraocular pressure in man","volume":"7","author":"Purnell","year":"1975","journal-title":"Annals of Ophthalmology"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0785","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.plefa.2008.09.022","article-title":"Neuroprotectin D1 inhibits retinal ganglion cell death following axotomy","volume":"79","author":"Qin","year":"2008","journal-title":"Prostaglandins, Leukotrienes, and Essential Fatty Acids"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0790","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22115793","article-title":"A comprehensive review: Sphingolipid metabolism and implications of disruption in sphingolipid homeostasis","volume":"22","author":"Quinville","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0795","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9101284","article-title":"The role of vitamins in neurodegenerative disease: An update","volume":"9","author":"Rai","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0800","doi-asserted-by":"crossref","DOI":"10.3390\/nu10030359","article-title":"The effect of vitamins on glaucoma: A systematic review and meta-analysis","volume":"10","author":"Ramdas","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0805","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s10654-012-9672-z","article-title":"Nutrient intake and risk of open-angle glaucoma: The Rotterdam Study","volume":"27","author":"Ramdas","year":"2012","journal-title":"European Journal of Epidemiology"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0810","doi-asserted-by":"crossref","DOI":"10.1016\/j.npep.2021.102196","article-title":"Potentiation of microglial endocannabinoid signaling alleviates neuroinflammation in Alzheimer\u2019s disease","volume":"90","author":"Rapaka","year":"2021","journal-title":"Neuropeptides"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0815","doi-asserted-by":"crossref","first-page":"959","DOI":"10.2174\/1570159X15666170724104305","article-title":"Neuroprotection by (endo)Cannabinoids in Glaucoma and Retinal Neurodegenerative Diseases","volume":"16","author":"Rapino","year":"2018","journal-title":"Current Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0820","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.plefa.2005.11.007","article-title":"Primary open-angle glaucoma patients have reduced levels of blood docosahexaenoic and eicosapentaenoic acids","volume":"74","author":"Ren","year":"2006","journal-title":"Prostaglandins, Leukotrienes, and Essential Fatty Acids"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0825","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1194\/jlr.S092007","article-title":"Niacin: An old lipid drug in a new NAD(+) dress","volume":"60","author":"Romani","year":"2019","journal-title":"Journal of Lipid Research"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0830","doi-asserted-by":"crossref","first-page":"8259371","DOI":"10.1155\/2018\/8259371","article-title":"Effects of Oral Supplementation with Docosahexaenoic Acid (DHA) plus Antioxidants in Pseudoexfoliative Glaucoma: A 6-Month Open-Label Randomized Trial","volume":"2018","author":"Romeo Villad\u00f3niga","year":"2018","journal-title":"Journal of Ophthalmology"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0835","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2020.110156","article-title":"Chronic central modulation of LPA\/LPA receptors-signaling pathway in the mouse brain regulates cognition, emotion, and hippocampal neurogenesis","volume":"108","author":"Rosell-Valle","year":"2021","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0840","doi-asserted-by":"crossref","first-page":"5899","DOI":"10.1021\/cr2002799","article-title":"Endocannabinoid oxygenation by cyclooxygenases, lipoxygenases, and cytochromes P450: Cross-talk between the eicosanoid and endocannabinoid signaling pathways","volume":"111","author":"Rouzer","year":"2011","journal-title":"Chemical Reviews"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0845","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.455","article-title":"Regulation of cell survival by sphingosine-1-phosphate receptor S1P1 via reciprocal ERK-dependent suppression of Bim and PI-3-kinase\/protein kinase C-mediated upregulation of Mcl-1","volume":"4","author":"Rutherford","year":"2013","journal-title":"Cell Death & Disease"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0850","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031014","article-title":"The role of Vitamin A in retinal diseases","volume":"23","author":"Sajovic","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0855","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1002\/jnr.22630","article-title":"Vitamin K has the potential to protect neurons from methylmercury-induced cell death in vitro","volume":"89","author":"Sakaue","year":"2011","journal-title":"Journal of Neuroscience Research"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0860","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.brainres.2008.09.020","article-title":"Stereo-selective neuroprotection against stroke with vitamin A derivatives","volume":"1241","author":"Sato","year":"2008","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0865","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1172\/JCI112147","article-title":"Long-term effects of dietary marine omega-3 fatty acids upon plasma and cellular lipids, platelet function, and eicosanoid formation in humans","volume":"76","author":"von Schacky","year":"1985","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0870","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0079-6123(08)01134-5","article-title":"Targeting excitotoxic\/free radical signaling pathways for therapeutic intervention in glaucoma","volume":"173","author":"Seki","year":"2008","journal-title":"Progress in Brain Research"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0875","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14122585","article-title":"Cannabidiol loaded topical ophthalmic nanoemulsion lowers intraocular pressure in normotensive dutch-belted rabbits","volume":"14","author":"Senapati","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0880","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature13479","article-title":"Pro-resolving lipid mediators are leads for resolution physiology","volume":"510","author":"Serhan","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0885","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.smim.2015.03.004","article-title":"The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution","volume":"27","author":"Serhan","year":"2015","journal-title":"Seminars in Immunology"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0890","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1172\/JCI97943","article-title":"Resolvins in inflammation: Emergence of the pro-resolving superfamily of mediators","volume":"128","author":"Serhan","year":"2018","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0895","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1167\/iovs.02-0323","article-title":"Human trabecular meshwork cell responses induced by bimatoprost, travoprost, unoprostone, and other FP prostaglandin receptor agonist analogues","volume":"44","author":"Sharif","year":"2003","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0900","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1242\/dev.121723","article-title":"Lysophosphatidic acid signalling in development","volume":"142","author":"Sheng","year":"2015","journal-title":"Development"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0905","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.brainres.2008.11.031","article-title":"Docosahexaenoic acid (DHA) has neuroprotective effects against oxidative stress in retinal ganglion cells","volume":"1251","author":"Shimazawa","year":"2009","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0910","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112197","article-title":"Updates on sphingolipids: Spotlight on retinopathy","volume":"143","author":"Shiwani","year":"2021","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0915","doi-asserted-by":"crossref","first-page":"100037","DOI":"10.1194\/jlr.TR120000972","article-title":"Sphingolipids as critical players in retinal physiology and pathology","volume":"62","author":"Simon","year":"2021","journal-title":"Journal of Lipid Research"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0920","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3389\/fncel.2019.00246","article-title":"Sphingolipids as emerging mediators in retina degeneration","volume":"13","author":"Sim\u00f3n","year":"2019","journal-title":"Frontiers in Cellular Neuroscience"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0925","doi-asserted-by":"crossref","first-page":"1087647","DOI":"10.1155\/2016\/1087647","article-title":"Glia-neuron interactions in the retina can be studied in cocultures of muller cells and retinal ganglion cells","volume":"2016","author":"Skytt","year":"2016","journal-title":"BioMed Research International"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0930","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/sj.bjp.0703050","article-title":"The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)","volume":"129","author":"Smart","year":"2000","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0935","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0022-3565(24)35269-3","article-title":"Involvement of cannabinoid receptors in the intraocular pressure-lowering effects of WIN55212-2","volume":"292","author":"Song","year":"2000","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0940","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0014-2999(01)01438-8","article-title":"Cannabinoid CB(1) receptor expression, activation and detection of endogenous ligand in trabecular meshwork and ciliary process tissues","volume":"431","author":"Stamer","year":"2001","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0945","first-page":"119","article-title":"Ocular and optic nerve ischemia: Recognition and treatment with intravenous prostaglandin E1","volume":"53","author":"Steigerwalt","year":"2011","journal-title":"Panminerva Medica"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0950","first-page":"2442","article-title":"Localization of cannabinoid CB1 receptors in the human anterior eye and retina","volume":"40","author":"Straiker","year":"1999","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0955","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.exer.2004.12.003","article-title":"Stimulation of cannabinoid (CB1) and prostanoid (EP2) receptors opens BKCa channels and relaxes ocular trabecular meshwork","volume":"80","author":"Stumpff","year":"2005","journal-title":"Experimental Eye Research"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0960","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000016597","article-title":"Efficacy and safety of prostaglandin analogues in primary open-angle glaucoma or ocular hypertension patients: A meta-analysis","volume":"98","author":"Tang","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0965","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.freeradbiomed.2021.10.027","article-title":"Reported evidence of vitamin E protection against cataract and glaucoma","volume":"177","author":"Tanito","year":"2021","journal-title":"Free Radical Biology & Medicine"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0970","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0133582","article-title":"Correlation between Systemic Oxidative Stress and Intraocular Pressure Level","volume":"10","author":"Tanito","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0975","doi-asserted-by":"crossref","first-page":"617","DOI":"10.2147\/OPTH.S96433","article-title":"Omega-3 fatty acid supplementation improves dry eye symptoms in patients with glaucoma: Results of a prospective multicenter study","volume":"10","author":"Tellez-Vazquez","year":"2016","journal-title":"Clinical Ophthalmology"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0980","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global prevalence of glaucoma and projections of glaucoma burden through 2040: A systematic review and meta-analysis","volume":"121","author":"Tham","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0985","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1167\/iovs.08-3146","article-title":"Resolvins E1 and D1 in choroid-retinal endothelial cells and leukocytes: Biosynthesis and mechanisms of anti-inflammatory actions","volume":"50","author":"Tian","year":"2009","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0990","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1167\/iovs.16-19275","article-title":"Oxidative stress-induced dysfunction of muller cells during starvation","volume":"57","author":"Toft-Kehler","year":"2016","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.pharmthera.2023.108412_bb0995","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s11064-014-1289-z","article-title":"Limited energy supply in Muller cells alters glutamate uptake","volume":"39","author":"Toft-Kehler","year":"2014","journal-title":"Neurochemical Research"},{"key":"10.1016\/j.pharmthera.2023.108412_bb1000","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.mito.2017.02.002","article-title":"Mitochondrial function in Muller cells - Does it matter?","volume":"36","author":"Toft-Kehler","year":"2017","journal-title":"Mitochondrion"},{"key":"10.1016\/j.pharmthera.2023.108412_bb1005","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nrm809","article-title":"Myofibroblasts and mechano-regulation of connective tissue remodelling","volume":"3","author":"Tomasek","year":"2002","journal-title":"Nature Reviews. Molecular Cell Biology"},{"key":"10.1016\/j.pharmthera.2023.108412_bb1010","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/01.ijg.0000212260.04488.60","article-title":"Effect of sublingual application of cannabinoids on intraocular pressure: A pilot study","volume":"15","author":"Tomida","year":"2006","journal-title":"Journal of Glaucoma"},{"issue":"Suppl. 1","key":"10.1016\/j.pharmthera.2023.108412_bb1015","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1016\/j.survophthal.2008.08.010","article-title":"Update on the mechanism of action of topical prostaglandins for intraocular pressure reduction","volume":"53","author":"Toris","year":"2008","journal-title":"Survey of Ophthalmology"},{"key":"10.1016\/j.pharmthera.2023.108412_bb1020","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1001\/archopht.122.12.1782","article-title":"Increase in outflow facility with unoprostone treatment in ocular hypertensive patients","volume":"122","author":"Toris","year":"2004","journal-title":"Archives of Ophthalmology"},{"key":"10.1016\/j.pharmthera.2023.108412_bb1025","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/IJG.0b013e31802fc6d3","article-title":"Effects of travoprost on aqueous humor dynamics in patients with elevated intraocular pressure","volume":"16","author":"Toris","year":"2007","journal-title":"Journal of Glaucoma"},{"key":"10.1016\/j.pharmthera.2023.108412_bb1030","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101988","article-title":"Nicotinamide provides neuroprotection in glaucoma by protecting against mitochondrial and metabolic dysfunction","volume":"43","author":"Tribble","year":"2021","journal-title":"Redox Biology"},{"key":"10.1016\/j.pharmthera.2023.108412_bb1035","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23147806","article-title":"Ceramide and Sphingosine-1-Phosphate in Neurodegenerative Disorders and Their Potential Involvement in Therapy","volume":"23","author":"Tringali","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2023.108412_bb1040","first-page":"1306","article-title":"Uptake of cholesterol by the retina occurs primarily via a low density lipoprotein receptor-mediated process","volume":"12","author":"Tserentsoodol","year":"2006","journal-title":"Molecular Vision"},{"key":"10.1016\/j.pharmthera.2023.108412_bb1045","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1038\/s41598-018-36952-6","article-title":"Comprehensive measurements of hydroxylinoleate and hydroxyarachidonate isomers in blood samples from primary open-angle glaucoma patients and controls","volume":"9","author":"Umeno","year":"2019","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2023.108412_bb1050","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27154836","article-title":"Specialized pro-resolving mediators in neuroinflammation: Overview of studies and perspectives of clinical applications","volume":"27","author":"Valente","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.pharmthera.2023.108412_bb1055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2015.06.003","article-title":"Glia-neuron interactions in the mammalian retina","volume":"51","author":"Vecino","year":"2016","journal-title":"Progress in Retinal and Eye Research"},{"key":"10.1016\/j.pharmthera.2023.108412_bb1060","doi-asserted-by":"crossref","first-page":"7994","DOI":"10.3390\/ijms22157994","article-title":"Risk Factors for Retinal Ganglion Cell Distress in Glaucoma and Neuroprotective Potential Intervention","volume":"22","author":"Vernazza","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2023.108412_bb1065","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9103172","article-title":"Neuroinflammation in Primary Open-Angle Glaucoma","volume":"9","author":"Vernazza","year":"2020","journal-title":"Journal of Clinical Medicine"},{"key":"10.1016\/j.pharmthera.2023.108412_bb1070","article-title":"Sphingolipids as critical players in retinal physiology and pathology","volume":"62","author":"Victoria Simon","year":"2021","journal-title":"Journal of Lipid Research"},{"key":"10.1016\/j.pharmthera.2023.108412_bb1075","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.mito.2017.02.003","article-title":"Disturbed mitochondrial function restricts glutamate uptake in the human Muller glia cell line, MIO-M1","volume":"36","author":"Vohra","year":"2017","journal-title":"Mitochondrion"},{"key":"10.1016\/j.pharmthera.2023.108412_bb1080","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.4103\/1673-5374.238612","article-title":"Neuroprotection of the inner retina: Muller cells and lactate","volume":"13","author":"Vohra","year":"2018","journal-title":"Neural Regeneration Research"},{"key":"10.1016\/j.pharmthera.2023.108412_bb1085","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.survophthal.2012.08.010","article-title":"The role of inflammation in the pathogenesis of glaucoma","volume":"58","author":"Vohra","year":"2013","journal-title":"Survey of Ophthalmology"},{"key":"10.1016\/j.pharmthera.2023.108412_bb1090","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1167\/iovs.16-19131","article-title":"omega-3 tear film lipids correlate with clinical measures of dry eye","volume":"57","author":"Walter","year":"2016","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.pharmthera.2023.108412_bb1095","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1167\/iovs.07-0080","article-title":"Bimatoprost, prostamide activity, and conventional drainage","volume":"48","author":"Wan","year":"2007","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.pharmthera.2023.108412_bb1100","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/eye.2013.10","article-title":"Glaucoma and vitamins A, C, and E supplement intake and serum levels in a population-based sample of the United States","volume":"27","author":"Wang","year":"2013","journal-title":"Eye (London, England)"},{"key":"10.1016\/j.pharmthera.2023.108412_bb1105","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1001\/jamaophthalmol.2017.5702","article-title":"Association of Dietary Fatty Acid Intake With Glaucoma in the United States","volume":"136","author":"Wang","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.pharmthera.2023.108412_bb1110","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2014.3192","article-title":"The pathophysiology and treatment of glaucoma: A review","volume":"311","author":"Weinreb","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2023.108412_bb1115","first-page":"2772","article-title":"Prostaglandins increase matrix metalloproteinase release from human ciliary smooth muscle cells","volume":"38","author":"Weinreb","year":"1997","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.pharmthera.2023.108412_bb1120","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1089\/jop.2018.0120","article-title":"Inhibition of LPA(1) Signaling Impedes Conversion of Human Tenon's Fibroblasts into Myofibroblasts Via Suppressing TGF-\u03b2\/Smad2\/3 Signaling","volume":"35","author":"Wen","year":"2019","journal-title":"Journal of Ocular Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2023.108412_bb1125","series-title":"Eye research developments","author":"Westerhouse","year":"2009"},{"issue":"Suppl. 2","key":"10.1016\/j.pharmthera.2023.108412_bb1130","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/S0039-6257(97)80003-3","article-title":"The molecular biology and ocular distribution of prostanoid receptors","volume":"41","author":"Woodward","year":"1997","journal-title":"Survey of Ophthalmology"},{"key":"10.1016\/j.pharmthera.2023.108412_bb1135","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12886-016-0202-8","article-title":"Bimatoprost, latanoprost, and tafluprost induce differential expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases","volume":"16","author":"Yamada","year":"2016","journal-title":"BMC Ophthalmology"},{"key":"10.1016\/j.pharmthera.2023.108412_bb1140","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1167\/iovs.08-1920","article-title":"The role of lysophosphatidic acid receptor (LPA1) in the oxygen-induced retinal ganglion cell degeneration","volume":"50","author":"Yang","year":"2009","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.pharmthera.2023.108412_bb1145","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13578-022-00828-0","article-title":"Lipid metabolism and storage in neuroglia: Role in brain development and neurodegenerative diseases","volume":"12","author":"Yang","year":"2022","journal-title":"Cell & Bioscience"},{"key":"10.1016\/j.pharmthera.2023.108412_bb1150","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.preteyeres.2008.07.002","article-title":"Endocannabinoids in the retina: From marijuana to neuroprotection","volume":"27","author":"Yazulla","year":"2008","journal-title":"Progress in Retinal and Eye Research"},{"key":"10.1016\/j.pharmthera.2023.108412_bb1155","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1194\/jlr.R031278","article-title":"Sphingolipids: Regulators of crosstalk between apoptosis and autophagy","volume":"54","author":"Young","year":"2013","journal-title":"Journal of Lipid Research"},{"key":"10.1016\/j.pharmthera.2023.108412_bb1160","first-page":"476","article-title":"Association of n3 and n6 polyunsaturated fatty acids in red blood cell membrane and plasma with severity of normal tension glaucoma","volume":"8","author":"Yu","year":"2015","journal-title":"International Journal of Ophthalmology"},{"key":"10.1016\/j.pharmthera.2023.108412_bb1165","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1194\/jlr.R046458","article-title":"LPA receptor signaling: Pharmacology, physiology, and pathophysiology","volume":"55","author":"Yung","year":"2014","journal-title":"Journal of Lipid Research"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725823000761?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725823000761?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:33:24Z","timestamp":1759012404000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725823000761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":233,"alternative-id":["S0163725823000761"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108412","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is fat the future for saving sight? Bioactive lipids and their impact on glaucoma","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108412","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108412"}}